GENE ONLINE|News &
Opinion
Blog

Crohn’s disease
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
Weekly in Asia(0428-0503)
2019-05-09
LATEST
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top